Infectious diseases are among the most critical health problems for people living in both the developed and developing world. From HIV and malaria to emerging pathogens like Ebola to Zika virus, ID faculty strive to tackle current and rapidly evolving public health threats.

The Division of Infectious Diseases at the University of North Carolina at Chapel Hill is an internationally recognized leader in infectious disease research, training, and clinical care. We are committed to a broad range of clinical care, research and teaching activities in North Carolina and around the world on four continents. ID faculty and staff are extensively involved in prevention programs –  from community outreach to vaccine development. Learn about the history of our division.

Learn more about:


Research is focused on HIV and sexually transmitted infections, malaria and other vector-borne diseases, tuberculosis, influenza, biodefense and emerging pathogens, and hospital infection control.

Clinical Care

The UNC Infectious Diseases Clinic meets five days each week in a large and modern facility on the first floor of North Carolina Memorial Hospital, providing care for more than 2,300 patients. The clinic also offers treatment of infections in returning travelers.

Infectious Diseases Fellowship Training

The Infectious Disease fellowship program at UNC has provided outstanding training, research and patient care for more than 40 years. This is the only program in the US with an international training site approved by the ACGME.

Global Programs

International projects and programs have been integral to UNC Infectious Disease research and training activities for many years, and global health in general is a recognized strength at UNC. The University has made globalization one of its highest priorities, and in 2007 established the Institute for Global Health and Infectious Diseases (IGHID) to bolster global health efforts across the health affairs schools.

Breakthrough of the Year

The HPTN 052 study, led by IGHID Director Myron Cohen, was named the 2011 Breakthrough of the Year by the journal Science.

HIV Matters Podcast